Last reviewed · How we verify
NCT06358404
Developing a Peer Support Intervention for Depression in SCD
NA trial testing PeersCOG in Subjective Cognitive Decline in 30 participants. Currently enrolling.
30 April 2026
Quick facts
| Lead sponsor | Massachusetts General Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 30 |
| Start date | 1 May 2024 |
| Primary completion | 30 April 2026 |
| Estimated completion | 30 April 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- PeersCOG
Conditions studied
- Subjective Cognitive Decline — all drugs for Subjective Cognitive Decline →
- Depression in Old Age — all drugs for Depression in Old Age →
Sponsor
Massachusetts General Hospital
Who can join
60 and older, any sex, with Subjective Cognitive Decline or Depression in Old Age. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to assess the feasibility, acceptability, and fidelity of an 8-week intervention where peer coaches will deliver depression care to adults 60 years of age or older who have depression and subjective cognitive decline.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06358404
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Subjective Cognitive Decline
Currently open trials in the same condition.
- NCT07511270 — Prediction of Cognitive Test Performance Using AI-Based Analysis of Narrative Speech · NA · recruiting
- NCT07085663 — Exergame-assisted Simultaneous Motor-cognitive Training for Middle-aged Old Adults in China · NA · recruiting
- NCT06002477 — Attentional Mechanisms in SCD · EARLY_PHASE1 · recruiting
- NCT06335836 — The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Su · recruiting
- NCT06539403 — Thinking About Memory: How Confident Are You in Your Memory, and Does it Change With Age? · recruiting
Other Massachusetts General Hospital trials
Trials by the same sponsor.
- NCT03585946 — Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis · withdrawn
- NCT07214831 — A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerg · NA · not yet recruiting
- NCT06686901 — A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior · NA · not yet recruiting
- NCT05854212 — Behavioral Economics to Implement Nutrition Ranking in Food Pantries · NA · not yet recruiting
- NCT07323446 — The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06358404 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Massachusetts General Hospital
- Last refreshed: 12 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06358404.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing